Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

284
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
284
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

247
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
247
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

272
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
272

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to Impact of Prior Kidney Transplantation on Symptom Burden and Health-Related Quality of Life in Incident Dialysis Patients (Kid Med. 2026;8(6):101357).

Kidney medicine·2026
Same author

Immune hyperactivity in hemodialysis patients is associated with interferon gamma-induced trained immunity.

iScience·2026
Same author

Impact of Prior Kidney Transplantation on Symptom Burden and Health-Related Quality of Life in Incident Dialysis Patients.

Kidney medicine·2026
Same author

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients.

PloS one·2026
Same author

Comparable outcomes for old, older, and very old deceased donors in old kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Related Experiment Video

Updated: Jan 2, 2026

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

12.4K

Latest developments in living kidney donation.

Luuk B Hilbrands1

  • 1Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.

Current Opinion in Organ Transplantation
|December 14, 2019
PubMed
Summary
This summary is machine-generated.

Living donor kidney transplantation is optimal for end-stage renal disease. Expanding the donor pool requires careful consideration of risks, ethical concerns, and psychosocial outcomes for living kidney donors.

More Related Videos

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.1K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.9K

Related Experiment Videos

Last Updated: Jan 2, 2026

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

12.4K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.1K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.9K

Area of Science:

  • Nephrology
  • Transplantation Medicine
  • Surgical Innovation

Background:

  • Living donor kidney transplantation has seen significant growth over the past two decades.
  • Advances in donation methods and donor pool expansion have driven this increase.
  • Long-term risks associated with living kidney donation are now better understood.

Purpose of the Study:

  • To review the latest developments in living donor kidney transplantation.
  • To summarize advancements in living donation modes and donor pool expansion.
  • To discuss the current understanding of long-term risks for living kidney donors.

Main Methods:

  • Review of recent meta-analyses and studies on living kidney donation.
  • Analysis of outcomes in ABO-incompatible versus ABO-compatible transplantation.
  • Evaluation of kidney paired donation program extensions and advanced donation strategies.
  • Assessment of risks for living donors, including end-stage renal disease, obesity, and genetic factors (APOL1).
  • Consideration of psychosocial outcomes in living kidney donation.

Main Results:

  • ABO-incompatible transplantation shows reduced patient and graft survival compared to ABO-compatible.
  • Kidney paired donation can be expanded, but advanced donation raises ethical questions.
  • Living donors face an increased risk of end-stage renal disease, particularly obese donors and those with high-risk APOL1 genotypes.
  • Psychosocial outcomes for living kidney donors are gaining recognition.

Conclusions:

  • Living donor kidney transplantation remains the preferred treatment for end-stage renal disease.
  • Expanding the donor pool necessitates robust paired kidney donation programs and adequate cost reimbursement.
  • Alternative strategies like ABO-incompatible transplantation, higher-risk donors, financial incentives, and advanced donation present medical, ethical, and logistical challenges.
  • Careful donor selection and follow-up, addressing both medical and psychosocial aspects, are crucial.